Mild cognitive impairment: A cross-national comparison

E. Arnáiz, O. Almkvist, R. J. Ivnik, Eric George Tangalos, L. O. Wahlund, B. Winblad, Ronald Carl Petersen

Research output: Contribution to journalArticle

65 Citations (Scopus)

Abstract

Objective: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). Methods: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. Results: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE ε4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. Conclusions: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.

Original languageEnglish (US)
Pages (from-to)1275-1280
Number of pages6
JournalJournal of Neurology, Neurosurgery and Psychiatry
Volume75
Issue number9
DOIs
StatePublished - Sep 2004

Fingerprint

Alzheimer Disease
Logistic Models
Learning
Neuropsychological Tests
Proportional Hazards Models
Sweden
Cognitive Dysfunction
Genotype
Education
Population

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Neuroscience(all)
  • Psychiatry and Mental health

Cite this

Mild cognitive impairment : A cross-national comparison. / Arnáiz, E.; Almkvist, O.; Ivnik, R. J.; Tangalos, Eric George; Wahlund, L. O.; Winblad, B.; Petersen, Ronald Carl.

In: Journal of Neurology, Neurosurgery and Psychiatry, Vol. 75, No. 9, 09.2004, p. 1275-1280.

Research output: Contribution to journalArticle

Arnáiz, E. ; Almkvist, O. ; Ivnik, R. J. ; Tangalos, Eric George ; Wahlund, L. O. ; Winblad, B. ; Petersen, Ronald Carl. / Mild cognitive impairment : A cross-national comparison. In: Journal of Neurology, Neurosurgery and Psychiatry. 2004 ; Vol. 75, No. 9. pp. 1275-1280.
@article{b1185d069d1546f99d9f0d3caa3d0c5c,
title = "Mild cognitive impairment: A cross-national comparison",
abstract = "Objective: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). Methods: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. Results: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE ε4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. Conclusions: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.",
author = "E. Arn{\'a}iz and O. Almkvist and Ivnik, {R. J.} and Tangalos, {Eric George} and Wahlund, {L. O.} and B. Winblad and Petersen, {Ronald Carl}",
year = "2004",
month = "9",
doi = "10.1136/jnnp.2003.015032",
language = "English (US)",
volume = "75",
pages = "1275--1280",
journal = "Journal of Neurology, Neurosurgery and Psychiatry",
issn = "0022-3050",
publisher = "BMJ Publishing Group",
number = "9",

}

TY - JOUR

T1 - Mild cognitive impairment

T2 - A cross-national comparison

AU - Arnáiz, E.

AU - Almkvist, O.

AU - Ivnik, R. J.

AU - Tangalos, Eric George

AU - Wahlund, L. O.

AU - Winblad, B.

AU - Petersen, Ronald Carl

PY - 2004/9

Y1 - 2004/9

N2 - Objective: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). Methods: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. Results: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE ε4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. Conclusions: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.

AB - Objective: The main aim of this collaborative study was to assess the comparability of the most commonly used criteria for mild cognitive impairment (MCI) by comparing the cognitive performance of patients with MCI from the Mayo Clinic (USA) and the Karolinska Institutet (Sweden). Methods: Standardised neuropsychological test scores were used to compare the two samples from the two institutions with regard to the number of cognitive domains in which performance was below 1.5 SD. Possible predictors for the conversion from MCI to Alzheimer's disease (AD) were assessed. Results: When the two institutions were considered together in the Cox proportional hazard model, the number of affected cognitive domains below 1.5 SD was a significant predictor of time to AD diagnosis with age, education, and APOE ε4 genotype entered into the same model as covariates. The number of affected cognitive areas remained as a significant predictor when the institutions were considered separately. The logistic regression model of conversion to AD showed that only tests assessing learning and retention were predictors of developing AD. Conclusions: Differences in population as well as in methodology of case ascertainment as well as other aspects may account for the observed variability between samples of patients with MCI. The number of impaired cognitive factors at baseline can predict the progression from MCI to AD. Furthermore, tests assessing learning and retention are the best predictors for progression to AD.

UR - http://www.scopus.com/inward/record.url?scp=4344707948&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344707948&partnerID=8YFLogxK

U2 - 10.1136/jnnp.2003.015032

DO - 10.1136/jnnp.2003.015032

M3 - Article

C2 - 15314114

AN - SCOPUS:4344707948

VL - 75

SP - 1275

EP - 1280

JO - Journal of Neurology, Neurosurgery and Psychiatry

JF - Journal of Neurology, Neurosurgery and Psychiatry

SN - 0022-3050

IS - 9

ER -